Gene · 3921
Papers1,692
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,692
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomics research of SARS-CoV-2 and COVID-19 disease. | Med Rev (2021) | 2022 | 37724330 | PubTator, text mining | PubMed |
| On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications. | Front Oncol | 2022 | 36844925 | PubTator, text mining | PubMed |
| A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8. | Biomater Biosyst | 2022 | 36824375 | PubTator, text mining | PubMed |
| Differential haplotype expression in class I MHC genes during SARS-CoV-2 infection of human lung cell lines. | Front Immunol | 2022 | 36818472 | PubTator, text mining | PubMed |
| Natural biomolecules and derivatives as anticancer immunomodulatory agents. | Front Immunol | 2022 | 36700235 | PubTator, text mining | PubMed |
| Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis. | Int J Mol Sci | 2022 | 36613784 | PubTator, text mining | PubMed |
| Phosphodiesterase 5 Inhibitor Potentiates Epigallocatechin 3-O-Gallate-Induced Apoptotic Cell Death via Activation of the cGMP Signaling Pathway in Caco-2 Cells. | Curr Issues Mol Biol | 2022 | 36547087 | PubTator, text mining | PubMed |
| Anticarcinogenic potentials of tea catechins. | Front Nutr | 2022 | 36545470 | PubTator, text mining | PubMed |
| A signal recognition particle-related joint model of LASSO regression, SVM-RFE and artificial neural network for the diagnosis of systemic sclerosis-associated pulmonary hypertension. | Front Genet | 2022 | 36518216 | PubTator, text mining | PubMed |
| Adsorption of extracellular proteases and pyocyanin produced by Pseudomonas aeruginosa using a macroporous magnesium oxide-templated carbon decreases cytotoxicity. | Curr Res Microb Sci | 2022 | 36518171 | PubTator, text mining | PubMed |
| A Signaling Crosstalk Links SNAIL to the 37/67 kDa Laminin-1 Receptor Ribosomal Protein SA and Regulates the Acquisition of a Cancer Stem Cell Molecular Signature in U87 Glioblastoma Neurospheres. | Cancers (Basel) | 2022 | 36497426 | PubTator, text mining | PubMed |
| The Expression Pattern of Adhesion G Protein-Coupled Receptor F5 Is Related to Cell Adhesion and Metastatic Pathways in Colorectal Cancer-Comprehensive Study Based on In Silico Analysis. | Cells | 2022 | 36497132 | PubTator, text mining | PubMed |
| Genomic analysis of Mycobacterium tuberculosis variant bovis strains isolated from bovine in the state of Mato Grosso, Brazil. | Front Vet Sci | 2022 | 36467663 | PubTator, text mining | PubMed |
| Identification of Key Genes and Pathways Associated with Preeclampsia by a WGCNA and an Evolutionary Approach. | Genes (Basel) | 2022 | 36421809 | PubTator, text mining | PubMed |
| Ribosomal control in RNA virus-infected cells. | Front Microbiol | 2022 | 36419416 | PubTator, text mining | PubMed |
| Placental transcriptional signatures associated with cerebral white matter damage in the neonate. | Front Neurosci | 2022 | 36389237 | PubTator, text mining | PubMed |
| Advancements on the Multifaceted Roles of Sphingolipids in Hematological Malignancies. | Int J Mol Sci | 2022 | 36361536 | PubTator, text mining | PubMed |
| Hypoxia-Regulated lncRNA USP2-AS1 Drives Head and Neck Squamous Cell Carcinoma Progression. | Cells | 2022 | 36359803 | PubTator, text mining | PubMed |
| Cellular Prion Protein Role in Cancer Biology: Is It A Potential Therapeutic Target? | Biomedicines | 2022 | 36359353 | PubTator, text mining | PubMed |
| Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis. | iScience | 2022 | 36339263 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3921/papers?page=10